Disclosures for "Multi-omic Liquid Biopsy Fingerstick Blood Test Platform for Neurological Disorders: Classification of Alzheimer’s Disease, Parkinson’s Disease and Myasthenia Gravis"
-
Dr. Seligmann has received personal compensation for serving as an employee of BioSpyder Technologies, Inc.. Dr. Seligmann has stock in BioSpyder Technologies, Inc..
-
Dr. Hernandez has received personal compensation for serving as an employee of BioSpyder Technologies.
-
Dr. Opichka has received personal compensation for serving as an employee of BioSpyder Technologies Inc.. Dr. Opichka has received research support from American Heart Association.
-
Dr. Camiolo has nothing to disclose.
-
Dr. Yeakley has received personal compensation for serving as an employee of BioSpyder Technologies. Dr. Yeakley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BioSpyder Technologies . Dr. Yeakley has stock in BioSpyder Technologies . Dr. Yeakley has received research support from NIH. Dr. Yeakley has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Chen has received personal compensation for serving as an employee of Biospyder. Dr. Chen has stock in Universal Sequencing.
-
Dr. Sahagian has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Sahagian has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. The institution of Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Sahagian has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. The institution of Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Sahagian has received intellectual property interests from a discovery or technology relating to health care.